Home › Type 2 Diabetes › Georgia › Roswell
Type 2 Diabetes clinical trials in Roswell, GA
5 studies for Type 2 Diabetes are looking for participants at sites in and around Roswell (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
RecruitingPhase 2
- North Georgia Clinical Research, Woodstock · 11 mi away
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
RecruitingPhase 3
- Research Site, Woodstock · 11 mi away
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
RecruitingPhase 3
- Research Site, Woodstock · 11 mi away
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
RecruitingPhase 3
- AURORA-2 Clinical Site, Canton · 17 mi away
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
RecruitingPhase 2
- North Georgia Clinical Research, Woodstock · 11 mi away
About Type 2 Diabetes
Type 2 Diabetes, previously referred to as Adult Onset Diabetes, is the more common type. Risk factors include obesity and family history.
More about Type 2 Diabetes on MedlinePlus
Type 2 Diabetes trials in other cities
- San Antonio, TX37 studies
- Houston, TX31 studies
- Orlando, FL24 studies
- Boston, MA20 studies
- Chicago, IL19 studies
- Dallas, TX19 studies
- Miami, FL19 studies
- Columbus, OH18 studies
- Las Vegas, NV18 studies
- Atlanta, GA17 studies
- San Diego, CA17 studies
- Los Angeles, CA16 studies
Other studies in Roswell
- Obesity13 studies
- Overweight10 studies
- Cardiovascular Disease4 studies
- Atherosclerosis4 studies
- High Blood Pressure4 studies
- Ulcerative Colitis3 studies
- Open-Angle Glaucoma3 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.